biote Corp. (BTMD) Tops Q2 Earnings Estimates

Group 1: Earnings Performance - biote Corp. reported quarterly earnings of $0.1 per share, exceeding the Zacks Consensus Estimate of $0.06 per share, but down from $0.14 per share a year ago, representing an earnings surprise of +66.67% [1] - Over the last four quarters, biote Corp. has surpassed consensus EPS estimates four times [2] - The company posted revenues of $48.86 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 1.37%, and down from $49.17 million year-over-year [2] Group 2: Stock Performance and Outlook - biote Corp. shares have declined approximately 32.5% since the beginning of the year, while the S&P 500 has gained 7.1% [3] - The company's earnings outlook will be crucial for future stock movements, with current consensus EPS estimates at $0.10 for the coming quarter and $0.61 for the current fiscal year [4][7] - The estimate revisions trend for biote Corp. was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Group 3: Industry Context - The Medical - Products industry, to which biote Corp. belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact biote Corp.'s performance [5]